KCA 098

Known as: KCA-098 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-1999
02419941999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Interactions of KCA-098 with heptakis(2,6-di-O-methyl)-beta-cyclodextrin (DM-beta-CyD) in solution and in the solid state were… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • table 1
Is this relevant?
2000
2000
The present study was undertaken to improve the oral absorption of KCA-098, an antiosteoporosis drug. In this study, the form 2… (More)
Is this relevant?
1999
1999
A new benzofuroquinoline derivative, 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoli ne-6-one (KCA-098), shows poor… (More)
  • figure 3
  • figure 1
  • figure 2
Is this relevant?
1999
1999
The metabolism of 3,9-bis(N,N-dimethylcarbamoyloxy)-5 H-benzofuro[3,2-c]-quinoline-6-one (KCA-098), a new inhibitor of bone… (More)
Is this relevant?
1996
1996
KCA-098 (3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinol ine-6-one), an analogue of coumestrol (a naturally occurring… (More)
Is this relevant?
1995
1995
Physicochemical properties of polymorphism of 3,9-bis-(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinol ine-6-one (KCA-098… (More)
Is this relevant?
1994
1994
We previously found that 3,9-bis(N,N-dimethylcarbamoyloxy)-5H- benzofuro[3,2-c]quinoline-6-one (KCA-098) inhibited bone… (More)
Is this relevant?
1994
1994
The effect of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoli ne-6-one designated as KCA-098) on the bone mineral… (More)
Is this relevant?
1994
1994
The effects of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoli ne-6-one (KCA-098), a derivative of coumestrol, on… (More)
Is this relevant?
1994
1994
We have developed a simple model of osteopenia in rats which is induced by confinement without requiring surgical operation. Each… (More)
Is this relevant?